Chethana Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-11-2024
- Paid Up Capital ₹ 3.00 M
as on 16-11-2024
- Company Age 5 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 18.00 Cr
as on 16-11-2024
- Revenue 0.82%
(FY 2023)
- Profit -5.14%
(FY 2023)
- Ebitda -0.61%
(FY 2023)
- Net Worth 44.37%
(FY 2023)
- Total Assets 4.91%
(FY 2023)
About Chethana Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹18.00 Cr.
Prabhat Agrawal, Praveen, and Kulambi Prakash serve as directors at the Company.
- CIN/LLPIN
U51909KA2019PTC123150
- Company No.
123150
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Apr 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Davangere, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Chethana Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prabhat Agrawal  | Director | 06-Aug-2019 | Current |
| Praveen | Director | Current | |
| Kulambi Prakash | Whole-Time Director | 03-Apr-2019 | Current |
Financial Performance and Corporate Structure Insights of Chethana Pharma.
Chethana Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.82% increase. The company also saw a slight decrease in profitability, with a 5.14% decrease in profit. The company's net worth Soared by an impressive increase of 44.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chethana Pharma?
In 2023, Chethana Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chirag Medicare Solutions Private LimitedActive 5 years 8 monthsPrabhat Agrawal, Praveen and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Dec 2020 | ₹18.00 Cr | Open |
How Many Employees Work at Chethana Pharma?
Chethana Pharma has a workforce of 135 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chethana Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chethana Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
